Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000 participants
OBSERVATIONAL
2017-01-01
2025-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Ischaemic Stroke Observational Study
NCT03333980
Optical Coherence Tomography for Intracranial Atherosclerotic Stenosis
NCT05550077
The Impact of Anti-thrombosis on Cerebral Microbleeds and Intracranial Hemorrhage in Ischemic Stroke Patients
NCT03571763
Symptomatic Carotid Outcomes Registry
NCT05300737
Chongqing Intracerebral Hemorrhage Study
NCT03085472
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
patients without any history of stroke
No interventions assigned to this group
Ischemic Stroke
patients with an episode of neurological dysfunction caused by focal cerebral, spinal, or retinal infarction within 72 hours.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* For control group, without any history of stroke
Exclusion Criteria
* Hemorrhagic Stroke
* Previous Ischemic Stroke For control group
* The expected life expense less than 3 years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Xi'an No.3 Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tian Ye, PhD
Role: PRINCIPAL_INVESTIGATOR
Xi'an No.3 Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xi'an No.3 Hospital
Xi’an, Shanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Tian Ye, doctor
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NDIS001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.